Treatment dilemma of craniopharyngioma and its molecular targeted therapy
Craniopharyngioma is a benign tumor of WHO grade Ⅰ. As the location of craniopharyngioma is deep, around which the peripheral structure is complex, the tumor adheres closely to the pituitary stalk and hypothalamus, and a small number of craniopharyngioma have the growth characteristics of malignant...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tianjin Huanhu Hospital
2020-03-01
|
| Series: | Chinese Journal of Contemporary Neurology and Neurosurgery |
| Subjects: | |
| Online Access: | http://www.cjcnn.org/index.php/cjcnn/article/view/2096 |